Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
Valentín García‐Gutiérrez, Massimo Breccia, Elias Jabbour, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Chronic myeloid leukaemia: Biology and therapy
Yun Wang, Zhi-Jian Liang, Robert Peter Gale, et al.
Blood Reviews (2024) Vol. 65, pp. 101196-101196
Closed Access | Times Cited: 8
Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies
Zhulan Cai, Shunyao Xu, Chen Liu
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 17
Open Access | Times Cited: 7
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
Lucía Pérez‐Lamas, Alejandro Luna, Concepción Boqué, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1045-1045
Open Access | Times Cited: 14
Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies
Fang Cheng, Qiling Xu, Qiang Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Sol–gel synthesis of strontium ferrate (SrFeO3) nanoparticles and evaluation of anti-leukemic effects against leukemic cell lines
Mojgan Taeby, Muhammad Hossein Ashoub, Mahsa Asghari, et al.
Journal of Sol-Gel Science and Technology (2023) Vol. 109, Iss. 1, pp. 56-65
Closed Access | Times Cited: 12
Isolated Central Nervous System Infiltrated and Progressed to Acute Myeloid Leukemia from Chronic Myeloid Leukemia with e1a3 BCR-ABL1 Transcript: A Rare Case Report and Literature Review
Xing Qiang, Wen Qin, Jia Li, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 35-43
Open Access
Semaglutide treatment for type 2 diabetes in a patient with chronic myeloid leukemia: A case report and review of the literature
Yuchen Zhang, Anxin Li
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
Fangyi Yao, Fangmin Zhong, Junyao Jiang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 993-1008
Open Access | Times Cited: 7
A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples
Heba M. Hashem, Eslam A. Ghaith, Amira Eladl, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 315, pp. 124262-124262
Closed Access | Times Cited: 2
Targeting Inhibitor of Apoptosis Proteins to Overcome Chemotherapy Resistance—A Marriage between Targeted Therapy and Cytotoxic Chemotherapy
Tiago Barroso, Cecília Melo-Alvim, Leonor Ribeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13385-13385
Open Access | Times Cited: 6
Influence of Fatty Acid Modification on the Anticancer Activity of the Antimicrobial Peptide Figainin 1
Zhenbin Han, Dongmei Feng, Wenxuan Wang, et al.
ACS Omega (2023) Vol. 8, Iss. 44, pp. 41876-41884
Open Access | Times Cited: 5
Antineoplastic agents associated with neutropenic enterocolitis in patients with malignancy: A quantitative safety signal analysis
Ali Amanati, Robbert Van Manen, Sarvin Sajedianfard, et al.
Journal of Oncology Pharmacy Practice (2024)
Closed Access | Times Cited: 1
Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia
Dan Wang, Jing He, Si‐Yang Maggie Liu, et al.
Cancer Letters (2024) Vol. 593, pp. 216970-216970
Open Access | Times Cited: 1
Platelet microparticles influence gene expression and modulate biological activities of chronic myeloid leukemia cells (K562)
Fariba Nikravesh, Roohollah Mirzaee Khalilabadi, Alireza Farsinejad, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
A Quality by Design (QbD) driven gradient high performance liquid chromatography method development for the simultaneous estimation of dasatinib and nilotinib in lipid nanocarriers
Srijita Sen, Om Prakash Ranjan
Journal of Chromatography B (2024) Vol. 1243, pp. 124229-124229
Closed Access | Times Cited: 1
All-trans retinoic acid inhibits glioblastoma progression and attenuates radiation-induced brain injury
Minyue Fu, Yiling Zhang, Bi Peng, et al.
JCI Insight (2024) Vol. 9, Iss. 21
Open Access | Times Cited: 1
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells
Seiichi Okabe, Akihiko Gotoh
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Developing therapeutic approaches for chronic myeloid leukemia: a review
Veerandra Kumar, Jyotirmayee, Malkhey Verma
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 5, pp. 1013-1029
Closed Access | Times Cited: 4
Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase
Emmanuella Oyogoa, Lukas D. Streich, Philipp W. Raess, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5267-5267
Open Access | Times Cited: 1
Cellular and DNA Toxicity Study of Triphenyltin Ethyl Phenyl Dithiocarbamate and Triphenyltin Butyl Phenyl Dithiocarbamate on K562, Leukemia Cell Line
Asmah Hamid, Nor Fadilah Rajab, Yip Charmagne, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 58-65
Closed Access | Times Cited: 1
High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
Wang Rongyue, Su Yanze, Lin Zhiheng, et al.
Research Square (Research Square) (2024)
Open Access
COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
Zilu Zhang, Jingtao Huang, Luxiang Wang, et al.
Blood Science (2024) Vol. 6, Iss. 2, pp. e00183-e00183
Open Access
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study
Fekadu Urgessa, Boki Lengiso, Aster Tsegaye, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Molecular targets for metastasis-directed therapy in malignant tumors
Vitalina Bodenko, M. S. Larkina, A. A. Prach, et al.
Bulletin of Siberian Medicine (2024) Vol. 23, Iss. 2, pp. 101-113
Open Access
Page 1 - Next Page

Scroll to top